C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation
Transplant International · 2024
DOI: 10.3389/ti.2024.13407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Yuko Miwa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Disease and Transplant Immunology, Aichi Medical University School of Medicine, Nagakute, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, ABO Blood-Group System, Blood Group Incompatibility. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In ABO blood group incompatible kidney transplantation (ABO-I), potential issues on acute antibody-mediated rejection (ABMR) remain to be solved. This study aimed to assess the risk factors of acute ABMR using recipient- or donor-derived specimens. Quantitative analysis of A/B antigen expression was conducted in 104 donor kidney tissues (Kt), platelets (Plt), and red blood cells (RBC) by immunohistochemical staining or flow cytometry (FCM). ABO-I pre-transplant recipient serum samples (ABMR = 12, non-ABMR = 27) were extracted by propensity score matching. Anti-A antibody titers of IgM, IgG and IgG subclasses, and C1q binding ability (%) on antibody were measured using RBC-FCM. No association was observed between ABMR and A/B antigen expression levels in donor’s Plt, RBC, or Kt. In recipient’s sample, C1q-IgG binding ability was significantly higher in the ABMR group than in the non-ABMR group (C1q−IgG: 9.04% vs. 5.93% p = 0.049). Neither the A/B antigen expression level in donors (grafts) nor anti-blood group IgG/IgM antibodies in recipient sera before desensitization seemed to influence ABMR incidence in ABO-I. In contrast, C1q-IgG binding ability could be a potential predictor for ABMR in ABO-I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kidney Disease and Transplant Immunology, Aichi Medical University School of Medicine, Nagakute, Japan.
- Biostatistics Center, Kurume University, Kurume, Japan.
- Department of Transplant Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
- Department of Transplant Surgery, Toyohashi Municipal Hospital, Toyohashi, Japan.
- Department of Nephrology, Masuko Memorial Hospital, Nagoya, Japan.
- Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Japan.
Zitieren
APA
Miwa, Y., Iwasaki, K., Murotani, K., Okada, M., Nagasaka, T., Watarai, Y., Takeda, A., Shizuku, M., Ashimine, S., Ishiyama, K., Maruyama, S., & Kobayashi, T. (2024). C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation. Transplant International. https://doi.org/10.3389/ti.2024.13407
Vancouver
Miwa Y, Iwasaki K, Murotani K, Okada M, Nagasaka T, Watarai Y, et al. C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation. Transplant International. 2024. doi:10.3389/ti.2024.13407
BibTeX
@article{Miwa2024,
author = {Miwa, Yuko and Iwasaki, Kenta and Murotani, Kenta and Okada, Manabu and Nagasaka, Takaharu and Watarai, Yoshihiko and Takeda, Asami and Shizuku, Masato and Ashimine, Satoshi and Ishiyama, Kohei and Maruyama, Shoichi and Kobayashi, Takaaki},
title = {C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13407}
}
EUVIMED